Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Poor Graft Function After Allo-HSCT
NCT01763086Phase 2Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2013
- Primary completion
- Jan 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in poor graft function (PGF), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
poor graft function (PGF)
Beyond the preview
Go deeper on NCT01763086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763086.